TGF-β2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism
Hirokazu Takahashi, Laurie J. Goodyear(Joslin Diabetes Center), Jarna C. Hannukainen(Turku PET Centre), Joram D. Mul(Netherlands Institute for Neuroscience), Roeland J.W. Middelbeek(Joslin Diabetes Center), Michael F. Hirshman(Joslin Diabetes Center), Mohamad Azhar(University of South Carolina), Christiano R. R. Alves(Harvard University), Søren Nielsen, Estelle Balan(Joslin Diabetes Center), Pirjo Nuutila(Turku University Hospital), Yu‐Hua Tseng(Joslin Diabetes Center), Matthew D. Lynes(Joslin Diabetes Center), C. Ronald Kahn(Joslin Diabetes Center), Kawai So(Brigham and Women's Hospital), Bente Klarlund Pedersen(University of Copenhagen), Kari K. Kalliokoski(University of Turku), Kristin I. Stanford(The Ohio State University), Jonathan M. Dreyfuss(Joslin Diabetes Center), Masaji Sakaguchi(Kumamoto University), Hui Pan(Université Paris Cité), Pasquale Nigro(Joslin Diabetes Center), Ruidan Xue(Joslin Diabetes Center), Rebecca Ryan
Cited by 207
Related Papers
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
|Scandinavian Journal of Medicine and Science in Sports|2015|3.5k
Antioxidants prevent health-promoting effects of physical exercise in humans
|Proceedings of the National Academy of Sciences|2009|1.6k
Insulin Receptor Signaling in Normal and Insulin-Resistant States
|Cold Spring Harbor Perspectives in Biology|2014|1.4k
Evidence for prescribing exercise as therapy in chronic disease
|Scandinavian Journal of Medicine and Science in Sports|2006|1.4k